Skip to main content
. 2023 May 26;42(6):112621. doi: 10.1016/j.celrep.2023.112621

Figure 2.

Figure 2

The E406W mutation dampens ACE2 binding severely

(A–C) Biolayer interferometry binding analysis of monomeric human ACE2 to immobilized Wuhan-Hu-1 (A), Alpha (N501Y, B), or E406W (C) RBDs.

(D) Mutation effects on avidity for dimeric human ACE2 as measured by yeast surface display19 for the E406W mutation and RBD mutations found in human-derived SARS-CoV-2 isolates deposited in GISAID as of September 27, 2021, across increasing frequency thresholds.